You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review

Article info

Article menu
Emerging technologies, pharmacology and therapeutics
Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review

Authors

  • Rishi Raj Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, Pikeville Medical Center, Pikeville, Kentucky, USADepartment of Internal Medicine, University of Pikeville Kentucky College of Osteopathic Medicine, Pikeville, Kentucky, USA PubMed articlesGoogle scholar articles
  • Rahul Mishra Department of Internal Medicine, Maulana Azad Medical College, New Delhi, Delhi, India PubMed articlesGoogle scholar articles
  • Nivedita Jha Department of Internal Medicine, Adichunchanagiri Institute of Medical Sciences, Mandya, Karnataka, India PubMed articlesGoogle scholar articles
  • Vivek Joshi Department of Biochemistry and Molecular Biology, Drexel University, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Ricardo Correa Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, The University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USADepartment of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, Phoenix VA Medical Center, Phoenix, Arizona, USA PubMed articlesGoogle scholar articles
  • Philip A Kern Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Kentucky College of Medicine, Lexington, Kentucky, USABarnstable Brown Diabetes Center, University of Kentucky, Lexington, Kentucky, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Rishi Raj; rishiraj91215{at}gmail.com; Dr Vivek Joshi; vivek21j{at}gmail.com
View Full Text

Citation

Raj R, Mishra R, Jha N, et al
Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
BMJ Open Diabetes Research and Care 2022;10:e002573. doi: 10.1136/bmjdrc-2021-002573

Publication history

  • Received August 27, 2021
  • Accepted November 9, 2021
  • First published January 3, 2022.
Online issue publication 
December 26, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.